PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Lean status in NAFLD is associated with higher frequency of PNPLA3 GG genotype, known to modify NAFLD progression.36–38 This underscores the need for deeper understanding of genetic factors and molecular mechanisms that lead to the heightened mortality risk in this population.